Ärzte und Hersteller gegen Nebenwirkungen.de
Apotheke adhoc Online 15.08.2019

German Industry Tries To Nip Homeopathy Debate In The Bud As France Decides In Favour Of De-Reimbursement
HBW insight 29.07.2019, S. 8 - 9
Responding quickly to the decision, the German Medicines Manufacturers' Association, BAH, and the Federal Association of the German Pharmaceutical Industry, BPI, the day after released a joint statement warning that such a de-reimbursement was "not applicable" to Germany.
_{(Printmedium – aus urheberrechtlichen Gründen hier nicht hinterlegt)}